2009
DOI: 10.1161/circresaha.109.196899
|View full text |Cite
|
Sign up to set email alerts
|

Genetic Fate Mapping Identifies Second Heart Field Progenitor Cells As a Source of Adipocytes in Arrhythmogenic Right Ventricular Cardiomyopathy

Abstract: Abstract-The phenotypic hallmark of arrhythmogenic right ventricular cardiomyopathy, a genetic disease of desmosomal proteins, is fibroadipocytic replacement of the right ventricle. Cellular origin of excess adipocytes, the responsible mechanism(s) and the basis for predominant involvement of the right ventricle are unknown. We generated 3 sets of lineage tracer mice regulated by cardiac lineage promoters ␣-myosin heavy chain (␣MyHC), Nkx2.5, or Mef2C. We conditionally expressed the reporter enhanced yellow fl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

11
150
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 137 publications
(161 citation statements)
references
References 38 publications
(52 reference statements)
11
150
0
Order By: Relevance
“…27 The same group of researchers also used genetic fate mapping techniques in mouse ARVD models to indicate that islet-1 positive (Isl1 + ) cardiac progenitor cells are the source of adipocytes in ARVD hearts. 34 However, misuse of terminologies for adipogenesis and later conflicting data from other groups [30][31][32] argue against the validity of this Pkg-β-catenin hypothesis. First, activation of peroxisome proliferator-activated receptor-γ (PPAR γ ) and its target genes was used as the marker for "adipogenesis (adipocyte formation)", which is absolutely incorrect and misleading.…”
Section: Modeling Arvd With Patient-specific Ipsc-cmsmentioning
confidence: 99%
See 1 more Smart Citation
“…27 The same group of researchers also used genetic fate mapping techniques in mouse ARVD models to indicate that islet-1 positive (Isl1 + ) cardiac progenitor cells are the source of adipocytes in ARVD hearts. 34 However, misuse of terminologies for adipogenesis and later conflicting data from other groups [30][31][32] argue against the validity of this Pkg-β-catenin hypothesis. First, activation of peroxisome proliferator-activated receptor-γ (PPAR γ ) and its target genes was used as the marker for "adipogenesis (adipocyte formation)", which is absolutely incorrect and misleading.…”
Section: Modeling Arvd With Patient-specific Ipsc-cmsmentioning
confidence: 99%
“…First, activation of peroxisome proliferator-activated receptor-γ (PPAR γ ) and its target genes was used as the marker for "adipogenesis (adipocyte formation)", which is absolutely incorrect and misleading. 27, 34 In fact, PPAR γ and its target genes are normally activated in several non-adipocyte tissues (eg, endothelial cells and macrophages), and could be abnormally activated by pathological conditions in liver (fatty livers) and CMs (diabetic cardiomyopathy). 35 Therefore, activation of PPAR γ and its target genes indicates the active process of "de novo lipogenesis" rather than cell transdifferentiation toward adipocytes.…”
Section: Modeling Arvd With Patient-specific Ipsc-cmsmentioning
confidence: 99%
“…The replacement of cardiac myocytes by fibrous and fatty tissue is also characteristic of ARVC. This likely involves differentiation of cardiac progenitor cells to adipocytes, a process that can be caused by suppression of canonical Wnt signalling (Lombardi et al, 2009). We and others have shown that plakoglobin, another armadillo protein, is inhibitory to Wnt signalling and its knockdown reduces the number of desmosomes in the intercalated discs (Martin et al, 2009;Lombardi et al, 2009).…”
Section: Introductionmentioning
confidence: 99%
“…Noteworthy, SB216763 was already known as an activator of the canonical Wnt signaling pathway and this study confirms an abnormal protein trafficking at the intercalated discs, rather than altered protein production in AC. These data, together with those by Lombardi et al [96] and by Kim et al [99], who were able to prevent cell degenerative changes using another Wnt activator, i.e. 6-bromoindirubin-3'-oxime, open the door to the identification of a curative therapy in AC, by targeting a final common pathway of disease pathogenesis.…”
Section: From Experimental Models To Target Therapymentioning
confidence: 55%
“…Knockdown of DSP in HL-1 cells causes the translocation of JUP into the nucleus, where it interferes with β-catenin/TCF transcriptional activity, leading to an adipogenic switch. Thereafter, by using genetic fate-mapping methods, the same group demonstrated that most of the adipocytes in AC originate from cardiac progenitors cells of the embryonic second heart field [96]. Furthermore, in mice overexpressing cardiac truncated JUP, suppression of the canonical Wnt signaling pathway and induction of proadipogenic genes expression due to nuclear translocation of JUP led to adipogenesis in c-kit + cardiac progenitor cells [97].…”
Section: Abnormal Intercellular Junction Proteins and Intracellular Smentioning
confidence: 99%